Dunlay R, Rodriguez M, Felsenfeld A J, Llach F
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City.
Kidney Int. 1989 Dec;36(6):1093-8. doi: 10.1038/ki.1989.305.
The effect of intravenous calcitriol on parathyroid function was evaluated in nine chronic hemodialysis patients with secondary hyperparathyroidism. Two micrograms of calcitriol were administered intravenously after dialysis thrice weekly for ten weeks. Parathyroid function was assessed by inducing hypo- and hypercalcemia with low calcium (1.0 mEq/liter) and high calcium (4.0 mEq/liter) dialyses before and after ten weeks of intravenous calcitriol therapy. To avoid hypercalcemia during calcitriol administration, the dialysate calcium was reduced to 2.5 mEq/liter. Parathyroid hormone (PTH) values (pg/ml) from dialysis-induced hypo- and hypercalcemia were plotted against serum ionized calcium, and the sigmoidal relationship between PTH and calcium was evaluated. Basal PTH levels fell from 902 +/- 126 pg/ml to 466 +/- 152 pg/ml (P less than 0.01) after therapy without a significant change in the serum total calcium concentration. The ionized calcium-PTH sigmoidal curve shifted to the left and downward after calcitriol therapy. The maximal PTH response during hypocalcemia decreased after calcitriol from 1661 +/- 485 pg/ml before calcitriol to 1031 +/- 280 pg/ml afterward (P less than 0.05). The PTH level at maximal inhibition due to hypercalcemia decreased from 281 +/- 76 pg/ml before calcitriol to 192 +/- 48 pg/ml afterward (P less than 0.05). The slope of the sigmoidal curve changed from -2125 +/- 487 to -1563 +/- 385 (P less than 0.05). The set point of ionized calcium (4.60 +/- .11 mg/dl before vs. 4.44 +/- .07 mg/dl after) did not change significantly with calcitriol therapy.(ABSTRACT TRUNCATED AT 250 WORDS)
在9例继发性甲状旁腺功能亢进的慢性血液透析患者中评估了静脉注射骨化三醇对甲状旁腺功能的影响。每周三次透析后静脉注射2微克骨化三醇,持续10周。在静脉注射骨化三醇治疗10周前后,通过低钙(1.0毫当量/升)和高钙(4.0毫当量/升)透析诱导低钙血症和高钙血症来评估甲状旁腺功能。为避免骨化三醇给药期间出现高钙血症,将透析液钙降至2.5毫当量/升。将透析诱导的低钙血症和高钙血症时的甲状旁腺激素(PTH)值(皮克/毫升)与血清离子钙作图,并评估PTH与钙之间的S形关系。治疗后基础PTH水平从902±126皮克/毫升降至466±152皮克/毫升(P<0.01),而血清总钙浓度无显著变化。骨化三醇治疗后,离子钙-PTH S形曲线向左下方移动。骨化三醇治疗后,低钙血症期间的最大PTH反应从骨化三醇治疗前的1661±485皮克/毫升降至1031±280皮克/毫升(P<0.05)。高钙血症导致的最大抑制时的PTH水平从骨化三醇治疗前的281±76皮克/毫升降至192±48皮克/毫升(P<0.05)。S形曲线的斜率从-2125±487变为-1563±385(P<0.05)。骨化三醇治疗后,离子钙的设定点(治疗前4.60±0.11毫克/分升 vs. 治疗后4.44±0.07毫克/分升)无显著变化。(摘要截短于250字)